Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma

Transfusion

Volumn 53, Issue SUPPL. 1, 2013, Pages

  Berséus, Olle ^a,b,c   Boman, Kjell ^a,b,c   Nessen, Shawn C ^a,b,c   Westerberg, Lars A ^a,b,c  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b Swedish Army Special Forces ^*  (Sweden)

^c 212th Combat Support Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD COMPONENT THERAPY; BLOOD GROUP ABO SYSTEM; BLOOD GROUP INCOMPATIBILITY; HEMOLYSIS; HUMAN; IMMUNOLOGY; INJURY; MORTALITY; PLASMA; REVIEW; RISK FACTOR;

ABO BLOOD-GROUP SYSTEM; BLOOD COMPONENT TRANSFUSION; BLOOD GROUP INCOMPATIBILITY; HEMOLYSIS; HUMANS; PLASMA; RISK FACTORS; WOUNDS AND INJURIES;

MLCS; MLOWN;

EID: 84874798554     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12045     Document Type: Article

References (89)

1. Repine TB, Perkins JG, Kauvar DS, Blackborne L. The use of fresh whole blood in massive transfusion. J Trauma 2006;60:S59-69.
2. Spinella PC. Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications. Crit Care Med 2008;36(Suppl.):S340-5.
3. Spinella PC, Perkins JG, Grathwohl KW, Beekley AC, Holcomb JB. Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries. J Trauma 2009; 66(Suppl.):S69-76.
4. Holcomb JB, Spinella PC. Optimal use of blood in trauma patients. Biologicals 2010;38:72-7.
5. Klein HG, Anstee DJ. Mollison's blood transfusion in clinical practice. 11th ed. Oxford: Blackwell Publishing Ltd; 2005.
6. Romano EL, Rossi-Devivo ML, Soyano A, Linares J. Destruction of IgG anti-A sensitized erythrocytes by mononuclear leucocytes from normal and ABO hemolytic disease affected children. Clin Exp Immunol 1984;55:451-8.
7. Springer GF, Horton RE, Forbes M. Origin of blood group B agglutinins in white leghorn chicks. J Exp Med 1959;110: 221.
8. Crawford H, Cutbush M, Falconer H, Mollison PL. Formation of immune A iso-antibodies with special reference to heterogenic stimuli. Lancet 1952;2:219-23.
9. Dausset J, Vidal G. Accidents de la transfusion chez de receveurs de grope A ayant recu du sang de groupe O; role de la vaccination par l'anatoxine diphterique et tetanique. Sang 1951;22:478-83.
10. Grove-Rasmussen M, Shaw RS, Marceau E. Hemolytic transfusion reaction in group A patient receiving group-O blood containing immune anti-A antibodies in high titer. Am J Clin Pathol 1953;23:828-32.
11. Gupte SC, Bathia HM. Anti-A and anti-B response after tetanus toxoid injections in normal adults and pregnant women. Indian J Med Res 1979;70:221-8.
12. Luzzio AJ. Demonstration of blood group substance bound Pasteurella pestis. Proc Soc Exp Biol Med 1969;131:853-8.
13. Springer GF. Influenza virus vaccine and blood group-Alike substances. Transfusion 1963;3:233-6.
14. Siber GR, Ambrosino DM, Gorgone BC. Blood-group-A-like substance present in a preparation of pneumococcal vaccine. Ann Intern Med 1982;96:580-6.
15. Camp FR Jr, Shields CE. Military blood banking-identification of the group O universal donors for transfusion of A, B and AB recipients-an enigma of two decades. Mil Med 1967;132:426-9.
16. Daniel-Johnson J, Leitman S, Klein H, Alter H, Lee-Stroka A, Scheinberg P, Pantin J, Quillen K. Probiotic-associated high titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions. Transfusion 2009; 49:1845-9.
17. Grove-Rasmussen M. Selection of "safe" group O blood. Transfusion 1966;6:331-5.
18. Mair B, Benson K. Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets. Transfusion 1998;38:51-5.
19. Josephson CD, Mukllis NC, Van Demark C, Hillyer CD. Significant numbers of apheresis-derived group O platelet units have "high-titer" anti-A/A,B: implications for transfusion policy. Transfusion 2004;44:805-8.
20. Tanabe K. Interinstitutional variation in the management of anti-A/B antibodies: the Japanese ABO-Incompatible Transplantation Committee survey. Transplantation 2007; 84:S13-6.
21. Kumlien G, Wilpert J, Säfvenberg J, Tydén G. Comparing the tube and gel techniques for ABO antibody titration, as performed in three European centers. Transplantation 2007;84:S17-9.
22. AuBuchon JP, de Wildt-Eggen J, Dumont LJ; for the Biomedical Excellence for Safer Transfusion Collaborative and the Transfusion Medicine Resource Committee of the College of American Pathologists. Reducing the variation in performance of antibody titrations. Vox Sang 2008;95: 57-65.
23. Cooling LL, Downes TA, Butch SH, Davenport RD. Anti-A and Anti-B titers in pooled group O platelets are comparable to apheresis platelets. Transfusion 2008;48: 2106-13.
24. Ottenberg R. Studies in isoagglutination. I. Transfusion and the question of intravascular agglutination. J Exp Med 1911;13:425-38.
25. Aubert EF, Boorman KE, Dodd BE. The agglutinininhibiting substance in human serum. J Pathol Bacteriol 1942;54:89-104.
26. Aubert EF, Boorman KE, Dodd BE, Loutit JF. The universal donor with high titer iso-agglutinins; the effect of anti-A iso-agglutinins on recipients of group A. BMJ 1942;1:659-64.
27. Gasser C. Akute hemolytische Krisen nach Plasma Transfusionen bei dystrophischtoxischen Saeuglingen. Helv Paediatr Acta 1945;1:38.
28. Alberton EC. Fatality due to transfusion of unpooled plasma. Am J Clin Pathol 1945;15:128-34.
29. Tisdall LH, Garland DM, Szanto PB, Hand AM, Bonnet J. The effects of the transfusion of group O blood of high isoagglutinin titer into recipients of other blood groups. Am J Clin Pathol 1946;16:193-206.
30. Tisdall LH, Garland DM, Wiener AS. A critical analysis of the value of the addition of A and B group-specific substances to group O blood for use as universal donor blood. J Lab Clin Med 1946;31:437-43.
31. Loutit JF, Mollison PL. Hemolytic icterus (acholuric jaundice) congenital and aquired. J Pathol Bacteriol 1946;38: 711-28.
32. Jandl JH, Jones AR, Castle WB. The destruction of red cells by antibodies in man. I. Observation on the sequestration and lysis of red cells altered by immune mechanisms. J Clin Invest 1957;36:1428-59.
33. Ervin DM, Young LE. Dangerous universal donors. I. Observations on destruction of recipient's A cells after transfusion of group O blood containing high titer of A antibodies of immune type not easily neutralizable by soluble A substance. Blood 1950;5:61-73.
34. Ervin DM, Christian RM, Young LE. Dangerous universal donors. II. Further observations on the in vivo and in vitro behaviour of isoantibodies of the immune type present in group O blood. Blood 1950;5:553-67.
35. Stevens AR Jr, Finch CA. A dangerous universal donor. Acute renal failure following transfusion of group O blood. Am J Clin Pathol 1954;24:612-20.
36. Chaplin H Jr. Hemolytic transfusion reaction associated with the transfusion of "dangerous universal donor" blood. Ann Intern Med 1955;43:1334-40.
37. Bull GM, Joekes AM, Lowe KG. Acute renal failure following intravascular hemolysis. Lancet 1957;ii:114-7.
38. Inwood MJ, Zuliani B. Anti-A hemolytic transfusion with packed O cells. Ann Intern Med 1978;89:515-6.
39. Barjas-Castro ML, Locatelli MF, Carvalho MA, Gilli SO, Castro V. Severe hemolysis in a group A recipient of a group O red blood cell unit. Transfus Med 2003;13:239-41.
40. Schwab CW, Shayne JP, Turner J. Immediate trauma resuscitation with type O uncrossmatched blood: a two-year prospective experience. J Trauma 1986;26:897-902.
41. Uncle D, Smejkal R Snyder R, Lessig M, Ross SE. Blood antibodies and uncrossmatched type O blood. Heart Lung 1991;20:284-6.
42. Ebert RV, Emerson CP. A clinical study of transfusion reactions. The hemolytic effect of group O blood and pooled plasma containing incompatible isoagglutinins. J Clin Invest 1946;25:627-38.
43. Barnes A Jr. Status of use of universal donor blood transfusion. Crit Rev Clin Lab Sci 1973;4:147-60.
44. Crosby WH, Akeroyd JH. Some immunohematologic results of large transfusions of group O blood in recipients of other blood groups. Blood 1954;9:103-16.
45. Barnes A. Transfusion of universal donor and uncrossmatched blood. Bibl Haematol 1980;46:132-42.
46. Kauvar DS, Holcomb JB, Norris GC, Hess J. Fresh whole blood transfusion: a controversial military practice. J Trauma 2006;61:181-4.
47. Nessen SC, Cronk DR, Edens J, Eastridge B, Little TR, Windsor J, Blackbourne LH, Holcomb JB. US Army twosurgeon teams operating in remote Afghanistan: an evaluation of split-based forward surgical team operations. J Trauma 2009;66:S37-47.
48. Perkins JG, Cap AP, Spinella PC, Schorr AF, Beekley AC, Grathwohl KW, Rentas FJ, Wade CE, Holcomb JB; the 31st Combat Support Hospital Research Group. Comparison of platelet transfusions as fresh whole blood versus apheresis platelets for massively transfused combat trauma patients. Transfusion 2011;51:242-52.
49. Sandler SG, Hermoni P, Sharon R, Superstine E. Blood transfusion therapy in the rear hospital during the Yom KippurWar (October 1973). Mil Med 1977;142:49.
50. Berséus O, Hervig T, Segatchian J. Military walking blood bank and the civilian blood service. Transf Apher Sci 2012; 46:341-2.
51. Spinella PC, Strandenes G, Bekkestad Rein E, Segatchian J, Hervig T. Symposium on fresh whole blood for severe hemorrhagic chock: from in-hospital to far forward resuscitations. Transf Apher Sci 2012;46:113-7.
52. Lundberg WB, McGinniss MH. Hemolytic transfusion reaction due to anti-A. Transfusion 1975;15:1-9.
53. Zoes C, Dube VE, Miller HJ, Vye MV. Anti-A1 in the plasma of platelet concentrates causing a hemolytic reation. Transfusion 1977;17:29-32.
54. McLeod BC, Sassetti RJ, Weens HJ, Vaithianathan T. Hemolytic transfusion reaction due to ABO-incompatible plasma in a platelet concentrate. Scand J Haematol 1982; 28:193-6.
55. Conway LT, Scott EP. Acute hemolytic transfusion reaction due to ABO-incompatible plasma in platelet apheresis concentrate [letter]. Transfusion 1984;24:423-34.
56. Pierce RN, Reich LM, Mayer K. Hemolysis following platelet transfusions reaction from ABO-incompatible donors. Transfusion 1985;25:60-2.
57. Ferguson DJ. Acute intravascular hemolysis after a platelet transfusion. Can Med Assoc J 1988;138:523-24.
58. Reis MD, Coovadia ASD. Transfusion of ABO-incompatible platelets causing severe hemolytic reaction. Clin Lab Haematol 1989;11:327-40.
59. Murphy MF, Hook S, Waters AH, Sterlini J, Whelan J, Davis C, Lister TA. Acute hemolysis after ABO-incompatible platelet transfusions. Lancet 1990;335:974-5.
60. Chow MP, Yung CH, Hu HY, Tzeng CH. Hemolysis after ABO-incompatible platelet transfusions. Chin Med J (Taipei) 1991;48:131-4.
61. McManigal S, Sims KL. Intravascular hemolysis secondary to ABO incompatible platelet products. Am J Clin Pathol 1999;111:202-6.
62. Larsson LG, Welsh VJ, Ladd DJ. Acute intravascular hemolysis secondary to out-of-group platelet transfusion. Transfusion 2000;40:902-6.
63. Valbonesi M, Deluigi MC, Lercari G, Florio G, Bruni R, Van Lint MT, Occhini D. Acute intravascular hemolysis in two patients transfused with dry-platelet units from the same ABO incompatible donor. J Artif Organs 2000;23:642-6.
64. Sauer-Heilborn A, Jahagirdar B, Burns L, Scofield T, Nollet KE. Passive antibody, aggressive hemolysis: an ABOincompatible platelet transfusion [abstract]. Transfusion 2002;42(Suppl.):SP304.
65. Gresens C, Gloster E, Wang L, Dimaio T. Acute hemolysis in a group A trauma patient who received a group O platelet apheresis unit [abstract]. Transfusion 2003;43(Suppl.): SP234.
66. Ozturk A, Turken O, Sayan O, Atasoyu EM. Acute intravascular hemolysis due to ABO-incompatible platelet transfusion. Acta Haematol 2003;110:211-2.
67. Fauzie D, Shirey RS, Thoman S, Bensen-Kennedy D, King KE. The risk of hemolytic transfusion reactions due to passively-acquired ABO-antibodies: a retrospective study of non-group O adult recipients of group O plateletpheresis transfusions [abstract]. Transfusion 2004;44(Suppl.): 36A.
68. Angiolillo A, Luban NLC. Hemolysis following an out-ofgroup platelet transfusion in an 8-month-old with Langerhans cell histiocytosis. J Pediatr Hematol Oncol 2004;26: 267-9.
69. Reinardt P, Wiesneth M, Schrezenmeier H, Seifried E. International forum: transfusion of apheresis platelets and ABO groups. Vox Sang 2005;88:212-3.
70. Sapatnekar S, Sharma G, Downes KA, Wiersma S, McGrath C, Yomtovian R. Acute hemolytic transfusion reaction in a pediatric patient following transfusion of apheresis platelets. J Clin Apher 2005;20:225-9.
71. Sadani DT, Urbaniak SJ, Bruce M, Tighe JE. Repeat ABOincompatible platelet transfusions leading to hemolytic transfusion reaction. Transfus Med 2006;16:375-9.
72. Harris SB, Josephson D, Cost CB, Hillyer CD. Nonfatal intravascular hemolysis in a pediatric patient after transfusion of a platelet unit with high-titer anti-A. Transfusion 2007;47:1412-7.
73. Oza KK. ABO mismatched platelet transfusion and acute intravascular hemolysis [abstract]. Transfusion 2002; 42(Suppl.):SP308.
74. Schwartz J, Depalma H, Kapoor K, Hamilton T, Grima K. Anti-A titers in group O single donor platelets: to titer or not to titer. Transfusion 2003;43:115A.
75. Pietersz RNI, Engelfriet CP, Reesink HW. International forum: transfusion of apheresis platelets and ABO groups. Vox Sang 2005;88:207-21.
76. Fung MK, Downes KA, Shulman IA. Transfusion of platelets containing ABO-incompatible plasma. Arch Pathol Lab Med 2007;131:909-16.
77. Cooling L. ABO and platelet transfusion therapy. Immunohematogy 2007;23:20-33.
78. Lozano M, Heddle N, Williamson LM, Wang G, AuBuchon JP, Dumont LJ. Practices associated with ABOincompatible platelet transfusions: a BEST collaborative international survey. Transfusion 2010;50:143-8.
79. Quillen K, Sheldon SL, Daniel-Johnson A, Lee-Stroka AH, Flegel WA. A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for hightiter ABO antibodies. Transfusion 2011;51:92-6.
80. Heal JM, Masel D, Rowe JM, Blumberg M. Circulating immune complexes involving the ABO system after platelet transfusion. Br J Haematol 1993;85:566-72.
81. Wagener FADTG, Eggert EG, Boerman OC, Oyen WJG, Verhohstad A, Abraham NG, Adema G, van Krooyk Y, de Witte T, Figdor CG. Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood 2001; 96:1802-11.
82. Yaser MH, Raval JS, Triutzi DJ, Blumberg N. ABOmismatched transfusions are not over-represented in febrile non-hemolytic transfusion reactions. Vox Sang 2012;102:175-7.
83. Stevens AR, Finch CA. A dangerous universal donor. Acute renal failure following transfusion of group O blood. Am J Clin Pathol 1954;24:612-20.
84. Lopas H, Birndorf NI, Robboy SJ. Experimental transfusion reactions and disseminated intravascular coagulation produced by incompatible plasma in monkeys. Transfusion 1971;11:196-203.
85. Rabiner F, O'Brien K, Peskin GW, Friedman LH. Further studies with stroma-free hemoglobin solution. Ann Surg 1971;171:615-22.
86. Schmidt PJ, Holland PV. Pathogenesis of the acute renal failure associated by incompatible transfusion. Lancet 1967;ii:1169-70.
87. Thompson A, McGarry AE, Valeri RC, Lieberthal W. Stroma-free hemoglobin increases blood pressure and GFR in the hypotensive rat: role of nitric oxide. J Appl Physiol 1994;77:2348-54.
88. Bowling F, Kerr W. Fresh whole blood transfusions in the austere environment. J Spec Oper Med 2011;11:3-37.
89. Kaufman R. A fresh take on whole blood [editorial]. Transfusion 2011;51:230-3.